Google owner Alphabet to tap U.S. dollar, euro bond markets
Alphabet Inc., the parent company of Google, is entering the U.S. dollar and euro debt markets with a multi-tranche senior unsecured notes issue....
China has achieved a significant medical milestone, with its drug regulator announcing the approval of the country's first domestically developed 9-valent human papillomavirus (HPV) vaccine.
In a landmark development for public health, China's drug regulator has given the green light to the nation's first domestically developed 9-valent human papillomavirus (HPV) vaccine. The approval, announced Wednesday, marks a significant turning point, ending over a decade of foreign companies dominating the lucrative and critical HPV vaccine market within the country.
The newly approved vaccine is designed to target nine distinct strains of the human papillomavirus, making it only the second vaccine of its kind globally to offer such broad protection. HPV vaccines are widely recognised as crucial tools in preventing cervical cancer in women and genital cancers and warts in both men and women.
Human Papillomavirus (HPV) is a very common virus, primarily spread through close physical intimacy, with many types. While some types can cause warts, certain "high-risk" types are responsible for nearly all cases of cervical cancer, as well as other cancers in both men and women. Vaccination is a key method of prevention.
This approval represents a major stride in China's push for self-sufficiency in key pharmaceutical and healthcare sectors. It is expected to significantly bolster the country's vaccination efforts, potentially improving accessibility and affordability of this vital preventative measure for millions of Chinese citizens. The domestic production could also reduce reliance on international supply chains, ensuring more stable access to the vaccine.
Experts believe that the introduction of a homegrown 9-valent HPV vaccine will not only address a significant public health need but also stimulate further innovation within China's biopharmaceutical industry. This development is poised to have a profound impact on public health outcomes across China, offering robust protection against HPV-related diseases.
Ukraine’s top military commander has confirmed that troops are facing “difficult conditions” defending the strategic eastern town of Pokrovsk against a multi-thousand Russian force.
Russia said on Monday that its troops had advanced in the eastern Ukrainian city of Pokrovsk, a transport and logistics hub that they have been trying to capture for over a year, but Ukraine said its forces were holding on.
Russia has launched its new nuclear-powered submarine, the Khabarovsk, at the Sevmash shipyard in Severodvinsk, the Defence Ministry said Saturday.
A man and a woman were killed and several others injured in a shooting on the Greek island of Crete on Saturday, in what police officials described as a family vendetta, reviving memories of the island’s long and complex history of inter-family violence.
U.S. President Donald Trump said he does not believe the United States is going to war with Venezuela despite growing tensions, though he suggested President Nicolás Maduro’s time in power may be nearing its end.
A prostate cancer blood test has been shown to reduce the risk of dying from the disease by 13% over two decades, researchers say.
Serious cases of a disorder of the large intestine are surging among Americans younger than 50, researchers say.
Russian President Vladimir Putin asked North Korean Foreign Minister Choe Son Hui during talks in the Kremlin on Monday to tell her country's leader Kim Jong Un that everything was "going to plan" in bilateral relations.
U.S. border czar says fentanyl should be considered a WMD.
U.S. states this week warned food aid recipients that their benefits may not be distributed in November if the federal government shutdown stretches into its fourth week.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment